UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 03/2020, Volume 64, Issue 3
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Doxycycline - adverse effects | Metronidazole - analogs & derivatives | Anti-Infective Agents - adverse effects | Alcohols - adverse effects | Doxycycline - pharmacokinetics | Tetracycline - adverse effects | Fluoroquinolones - pharmacokinetics | Fluoroquinolones - adverse effects | Azithromycin - adverse effects | Erythromycin - adverse effects | Azithromycin - pharmacokinetics | Erythromycin - pharmacokinetics | Drug Interactions | Metronidazole - pharmacokinetics | Alcohols - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Penicillins - pharmacokinetics | Metronidazole - adverse effects | Penicillins - adverse effects | Cephalosporins - pharmacokinetics | Anti-Bacterial Agents - adverse effects | Tetracycline - pharmacokinetics | Cephalosporins - adverse effects | Index Medicus
Journal Article
Neurology, ISSN 0028-3878, 10/2015, Volume 85, Issue 15, pp. 1332 - 1341
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Animals | Humans | Central Nervous System - drug effects | Risk | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Cephalosporins - adverse effects | Imipenem - adverse effects | Seizures - chemically induced | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2008, Volume 47, Issue 6, pp. 735 - 743
Fluoroquinolones | Prescription drugs | Emergency departments | Antibiotics | Sulfonamides | Articles and Commentaries | Patient care | Health care statistics | Adverse effects | Drug prescriptions | Allergies | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | United States - epidemiology | Adverse Drug Reaction Reporting Systems | Drug Hypersensitivity - epidemiology | Humans | Penicillins - adverse effects | Anti-Bacterial Agents - adverse effects | Emergency Service, Hospital - utilization | Cephalosporins - adverse effects | Drugs | Complications and side effects | Care and treatment | Emergency service | Usage | Hospitals | Adverse and side effects | Research | Risk factors | Studies | Side effects | Emergency medical care | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2010, Volume 125, Issue 2, pp. S126 - S137.e1
Allergy and Immunology | penicillin | graded challenge | angiotensin-converting enzyme inhibitors | radiocontrast media | cephalosporin | desensitization | Drug allergy | biologic modifiers | adverse drug reactions | carbapenem | local anesthetic | sulfonamide | drug hypersensitivity | tolerance | nonsteroidal anti-inflammatory drug | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Medical History Taking | Anti-HIV Agents - adverse effects | Humans | Drug Hypersensitivity - therapy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Contrast Media - adverse effects | Antineoplastic Agents - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Drug Hypersensitivity - diagnosis | beta-Lactams - adverse effects | Drug-Related Side Effects and Adverse Reactions - physiopathology | Drug Hypersensitivity - physiopathology | Drug-Related Side Effects and Adverse Reactions - diagnosis | Drug-Related Side Effects and Adverse Reactions - therapy | Lupus | Enzymes | Aspirin | Sulfonamides | Beta lactam antibiotics | Respiratory tract diseases | Salicylates | Drug therapy | Anesthetics | Allergic reaction | Nonsteroidal anti-inflammatory drugs | Drug dosages | Patients | Management decisions | Allergies | Penicillin | Index Medicus | Abridged Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 10/2014, Volume 59, Issue 8, pp. 1083 - 1091
Sexually transmitted diseases | Neisseria gonorrhoeae | Cephalosporins | Antimicrobials | Men | Clinical trials | Infections | Gonorrhea | Preventive medicine | ARTICLES AND COMMENTARIES | School enrollment | Gemifloxacin | Gonorrhea treatment | Gentamicin | Azithromycin | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Gastrointestinal Diseases - epidemiology | Naphthyridines - adverse effects | United States | Humans | Middle Aged | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Gastrointestinal Diseases - pathology | Adult | Female | Anti-Bacterial Agents - adverse effects | Gentamicins - adverse effects | Gentamicins - therapeutic use | Administration, Oral | Fluoroquinolones - therapeutic use | Treatment Outcome | Injections, Intramuscular | Gonorrhea - drug therapy | Fluoroquinolones - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Azithromycin - adverse effects | Neisseria gonorrhoeae - isolation & purification | Drug Therapy, Combination - methods | Azithromycin - therapeutic use | Naphthyridines - therapeutic use | Adolescent | Gastrointestinal Diseases - chemically induced | Care and treatment | Dosage and administration | Risk factors | Antimicrobial agents | Effectiveness | Drug therapy | Drug resistance | Product safety | Index Medicus | gentamicin | azithromycin | and Commentaries | gemifloxacin | gonorrhea treatment
Journal Article
Journal of dental research, ISSN 0022-0345, 9/2019, Volume 98, Issue 10, pp. 1081 - 1087
Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Administration, Oral | Adverse Drug Reaction Reporting Systems | Clarithromycin - adverse effects | Humans | Metronidazole - administration & dosage | England | Penicillins - administration & dosage | Clindamycin - adverse effects | Clindamycin - administration & dosage | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Penicillins - adverse effects | Amoxicillin - adverse effects | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Dentists | Clarithromycin | Data analysis | Clavulanic acid | Clindamycin | Hypersensitivity | Azithromycin | Erythromycin | Primary care | Manuscripts | Acids | Cephalosporins | Antibiotics | Tetracyclines | Penicillin | Amoxicillin | Metronidazole | Prescriptions | Penicillin V | Index Medicus | Dentistry
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2014, Volume 58, Issue 10, pp. 1377 - 1385
Toxic epidermal necrolysis | Scars | Corticosteroids | Antibiotics | Cephalosporins | Penicillin | Sepsis | ARTICLES AND COMMENTARIES | Stevens Johnson syndrome | Mortality rates | Allergies | Systemic antibiotics | SCARs | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Drug Eruptions - etiology | Humans | Middle Aged | Stevens-Johnson Syndrome - etiology | Drug Eruptions - therapy | Male | Glycopeptides - adverse effects | Eosinophilia | Carbapenems - adverse effects | Drug Eruptions - mortality | Quinolones - adverse effects | Acute Generalized Exanthematous Pustulosis - etiology | Quinolones - therapeutic use | Taiwan | Aged, 80 and over | Penicillins - adverse effects | Adult | Female | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Cephalosporins - adverse effects | Stevens-Johnson syndrome | Usage | Care and treatment | Diagnosis | Peptides | Mortality | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Cephalosporins | E coli | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article